{
  "name" : "dacemirror.sci-hub.se_journal-article_2ffbb957930f35cfa1417197bec58246_yekke-ghasemi2018.pdf",
  "metadata" : {
    "source" : "META",
    "title" : "Molecular design and synthesis of new dithiocarbazate complexes; crystal structure, bioactivities and nano studies",
    "authors" : [ "Zahra Yekke-ghasemi", "Reza Takjoo", "Mohammad Ramezani", "Joel T. Mague" ],
    "emails" : [ "r.takjoo@um.ac.ir" ],
    "sections" : [ {
      "heading" : null,
      "text" : "RSC Advances\nPAPER\nO pe\nn A\ncc es\ns A\nrt ic\nle . P\nub lis\nhe d\non 1\n4 D\nec em\nbe r\n20 18\n. D ow\nnl oa\nde d\non 1\n/2 0/\n20 19\n1 0:\n34 :0\n7 PM . T hi s ar tic le is li ce ns ed u nd er a C re at iv e C om m on s A ttr ib ut io nN on C om m er ci al\n3 .0\nU np\nor te\nd L\nic en\nce .\nView Article Online View Journal | View Issue\nMolecular design\naDepartment of Chemistry, Faculty of Sci Mashhad, Iran. E-mail: r.takjoo@um.ac.ir 880 5536 bPharmaceutical Research Center, School of P Sciences, Mashhad, Iran cDepartment of Chemistry, Tulane Universit † Electronic supplementary information ( contains the supplementary crystallograp crystallographic data in CIF or o 10.1039/c8ra07100d\nCite this: RSC Adv., 2018, 8, 41795\nReceived 25th August 2018 Accepted 24th September 2018\nDOI: 10.1039/c8ra07100d\nrsc.li/rsc-advances\nThis journal is © The Royal Society of C\nand synthesis of new dithiocarbazate complexes; crystal structure, bioactivities and nano studies†\nZahra Yekke-ghasemi,a Reza Takjoo, *a Mohammad Ramezanib and Joel T. Maguec\nThe syntheses of a new set of metal complexes MoO2L0(CH3OH), VOL0(CH3O)(CH3OH), MnL02, SnL 0 2, SnL 0Cl2 and SnL0I2 with a new ligand (L ¼ (2,20(disulfanediylbis((ethylthio)methylene)bis(hydrazin-2-yl-1-ylidene) bis(methanylylidene)) diphenol; L0 ¼ S-ethyl-3-(2-hydroxyphenyl)methylenedithiocarbazate are described along with characterization by elemental analysis, mass spectrometry, spectroscopic (IR, 1H- and 13C-\nNMR) and TGA techniques. The crystal structures of compounds were determined by single crystal X-ray\ndiffraction analysis and compared to powder X-ray diffraction (PXRD) patterns of the nano complexes\nobtained using ultrasonic methods. The PXRD results indicate that the compounds synthesized by\nultrasonic methods have high crystallinity. The compounds were evaluated in an in vitro cytotoxicity\nstudy with two human cancer cell lines. The results of this study revealed that all complexes exhibit good\ncytotoxic activity when compared to the clinical drug, cisplatin. Interaction of the samples with human\nserum albumin (HSA) was investigated using fluorescence spectrophotometric methods and the Stern–\nVolmer quenching constant (KSV) and free energy changes (DG) were calculated at 298 K. The fluorescence quenching method is used to determine the number of binding sites (n) and association\nconstants (Ka) at the same temperatures."
    }, {
      "heading" : "1. Introduction",
      "text" : "S-Alkyl/aryl dithiocarbazates as sulfur–nitrogen chelating agents are interesting in the context of coordination chemistry. Owing to hard nitrogen and so sulfur donor atoms, formation of ve-membered chelate rings can stabilize transition and nontransition metals in various oxidation states.1,2 Through reacting various aldehydes and ketones with dithiocarbazates multidentate ligands will form for which, depending on the different structures obtained upon coordination with metal ions, different biological applications including antibacterial, antifungal and anticancer activity could be obtained.3 A variety of coordination complexes and cytotoxic compounds have been investigated for the treatment of human cancer in recent years4,5 with cisplatin as the most widely used drug but its use is limited in medicine due to the side effects such as nephrotoxicity and drug resistance.6,7 Other studies have suggested that\nence, Ferdowsi University of Mashhad, ; rezatakjoo@yahoo.com; Tel: +98 513\nharmacy, Mashhad University of Medical\ny, New Orleans, LA 70118, USA ESI) available: CCDC 1851305–1851311 hic data for L and 1 to 6. For ESI and ther electronic format see DOI:\nhemistry 2018\ndithiocarbazates, due to the sulfur–nitrogen chelating functionality, can reduce these side effects.8 Thus complexation of tridentate ONS-chelating derivatives of dithiocarbazates with metals such as Mn,9 Sn,10 V11 and Mo12 should be interesting in chemotherapeutics especially with regard to antitumor effects.13 These metals are also known to accelerate drug action and play major roles in biological systems. For example, vanadium is present in the two enzymes of haloperoxidase and nitrogenase and also plays a role in the regulation of phosphate metabolism.14 Manganese exists at the catalytic center of the three enzymes manganese catalase, ribonucleotide reductase of certain bacteria and the photosystem II of green plants to facilitate the metabolism of the O2\nn unit15 and molybdenum is at the active sites of molybdoenzymes.16\nInvestigation of protein–ligand interactions helps us to understand the antitumor effects of metal complexes.17,18 Albumins as a major transporter of the proteins in blood plasma are good candidates for studying these interactions.19 HSA is responsible for carrying substances in the blood and is also able to carry pharmaceutical compounds with different chemical structures.20 Six linkages are identied for ligand binding on HSA.21,22 From these six sites, two major sites are responsible for binding with metals23 with the linkage being either covalent or non-covalent.24 In general, evaluation of drug–protein interaction in order to achieve optimal therapeutic dose and the awareness of drug–protein binding capacity is essential.25\nRSC Adv., 2018, 8, 41795–41809 | 41795\nO pe\nn A\ncc es\ns A\nrt ic\nle . P\nub lis\nhe d\non 1\n4 D\nec em\nbe r\n20 18\n. D ow\nnl oa\nde d\non 1\n/2 0/\n20 19\n1 0:\n34 :0\n7 PM . T hi s ar tic le is li ce ns ed u nd er a C re at iv e C om m on s A ttr ib ut io nN on C om m er ci al\n3 .0\nU np\nor te\nd L\nic en\nce .\nTherefore, in the present article, the new complexes of dithiocarbazates are designed, synthesized and characterized in order to examine their antitumor properties. The cytotoxic test of the compounds using MTT assay was performed against the Hela andMCF-7 cells. Also, the effects of dithiocarbazates in the presence of different metal ions on HSA are studied from a molecular point of view."
    }, {
      "heading" : "2. Experimental",
      "text" : ""
    }, {
      "heading" : "2.1. Materials and methods",
      "text" : "Human serum albumin (HSA 99%, fatty acid free) was purchased from Sigma Chemical Company and RPMI-1640 medium and fetal bovine serum (FBS) from GIBCO (Gaithersburg, USA). Penicillin and streptomycin were purchased from Biochrom AG (Berlin, Germany).\nAll other material and solvents were purchased and used without purication. IR spectra in the region 600–4000 cm 1 were recorded with a Buck 500 Scientic. Elemental analyses (CHNS) were performed with a Thermo Finnigan Flash 1112EA elemental analyzer. The EI-mass spectra were carried out using a Varian CH-7 instrument at 70 eV. Melting points were determined with an electrothermal digital melting point apparatus. 1H and 13C NMR spectra of compounds were recorded on a Bruker FUM-300 spectrometer using DMSO-d6 as solvent. TG analysis was performed with a TGA-50 SHIMADZU instrument at a heating rate of 10 C min 1 under air atmosphere from ambient temperature to 950 C. X-ray powder diffraction (XRD) measurements were recorded on a Philips diffractometer manufactured by X'pert with graphite monochromatized Cu-Ka radiation. Simulated XRD powder patterns were calculated by using MERCURY based on the single crystal data. The size and morphology of nanoparticles of CP have been studied by SEM, a Leo 1450 VP, Germany.\n2.2. Synthesis of (2,20-(disulfanediylbis((ethylthio)methylene)) bis(hydrazin-2-yl-1-ylidene)bis(methanylylidene))diphenol (L)\nCarbon disulde (7.75 g, 102 mmol) was added dropwise to a solution of hydrazine hydrate (5.00 g, 100 mmol), potassium hydroxide (6.00 g, 107 mmol), water (6 mL) and 25 mL of ethanol with stirring and cooling in an ice-salt bath for one hour. Ethyl bromide (10.35 g, 94.98 mmol) was added to the above mixture over 30 minutes. The reaction mixture was heated for 30 minutes to 25 C and then cooled down to 10 C. Cold distilled water (60 mL) was added to the above solution and a two-phase mixture was obtained. Salicylaldehyde (5.20 g, 24.58 mmol) solution in 30 mL of 75% ethanol, at room temperature, was added to the separated organic phase. The resulting yellow precipitate was ltered off, washed with water and dried in a vacuum desiccator over silica gel.\nColorless column-like crystals were obtained aer recrystallization from ethanol, yield: 5.79 g, 14.5% (based on the mass of the oily organic phase), mp: 151 C. Anal. calc. for C20H22N4O2S4 (478.67 g mol 1): C, 49.98; H, 5.03; N, 11.66; S, 26.68. Found: C, 50.07; H, 5.10; N, 11.36; S, 27.30%. IR (KBr), cm 1: n(OH) 3108 s, n(C]N) 1612 s, n(N-CSS) 1526 m, n(C–O) 1262 m, n(N–N) 1028 s.\n41796 | RSC Adv., 2018, 8, 41795–41809\nMass spectrometry, m/z (%): 239 (100) {M/2 ¼ L0}. 1H-NMR (300 MHz, DMSO-d6, 295 K) d: 1.298 (t, 3H, J ¼ 7.35 Hz, CH3), 3.202 (q, 2H, J¼ 7.35 Hz, CH2), 6.919 (m, 2H, H-3 and H-5), 7.316 (td, J ¼ 7.80 Hz, 1H, H-4), 7.669 (dd, J ¼ 7.77, 1.69 Hz, 1H, H-2), 10.259 (s, 1H, H-7). 13C-NMR (75.6 MHz, DMSO-d6, 296 K) d ppm: 14.37 (C10); 27.88 (C9); 127.87 (C1); 120.08 (C2); 132.65 (C3); 116.86 (C4); 157.70 (C5); 119.52 (C6); 145.15 (C7); 196.59 (C8)."
    }, {
      "heading" : "2.3. Synthesis of the metal complexes",
      "text" : "2.3.1. Synthesis of methanol-(2-[([(methylsulfanyl)(suldo) methylidene]hydrazinylidene)methyl]phenolato)-dioxido-molybdenum(VI) (1). MoO2(acac)2 (0.048 g, 0.195 mmol) was dissolved in dry methanol (3 mL) and added to solution of L (0.050 g, 0.200mmol) in the same solvent (3 mL). Themixture was stirred for 3 hours and then le to stand for 2 days whereupon the crystalline product which formed was ltered off and dried in a desiccator over anhydrous silica gel. Suitable crystals for X-ray analysis were obtained by diffusion of n-hexane into a methanolic solution of the complex.\nOrange block-like crystal, yield: 0.1 g, 68% (based on the metal salt). Mp: 230 C. Anal. calc. for C11H14MoN2O4S2 (398.32 g mol 1): C, 33.17; H, 3.54; N, 7.03; S, 16.10. Found: C, 32.00; H, 3.42; N, 6.76; S, 15.93%. IR (KBr), cm 1: n(OH) 3418 w, n(C]N) 1592 s, n(C–O) 1548 m, n(N–N) 1012 s. Mass spectrometry, m/z (%): 366 (98) {M-CH3OH}.\n1H-NMR (300 MHz, DMSOd6) d: 1.356 (t, 3H, J ¼ 7.31 Hz, CH3), 3.180 (m, 3H, OCH3), 4.131 (q, 2H, J ¼ 5.24 Hz, CH2), 6.970 (d, 1H, J ¼ 8.27 Hz, H-2), 7.086 (m, 1H, H-4), 7.575 (m, 1H, H-3), 7.789 (dd, 1H, J ¼ 1.75 and 7.86 Hz, H-5), 8.957 (S, 1H, H-7). 13C-NMR (75.6 MHz, DMSO-d6, 296 K) d ppm: 15.04 (C10); 28.27 (C9); 49.08 (C11); 136.21 (C1); 120.14 (C2); 135.68 (C3); 118.84 (C4); 121.77 (C5); 171.00 (C6); 160.15 (C7).\n2.3.2. Synthesis of methoxy-methanol-oxido-(2-(((thio(phenyl)methylene)hydrazono)methyl)phenolato)-vanadium(V) (2). 3 mL of a methanol solution of VO(acac)2 (0.022 g, 0.082 mmol) was added to L (0.020 g, 0.083 mmol) in 3mL of the same solvent. The mixture was reuxed for 2 h at 70 C on a water bath. The resulting solution was kept in a refrigerator for 2 days to generate crystals of the complex which were ltered off and dried in a desiccator over silica gel.\nDark yellow-brown thick plate-like crystal, yield: 0.1 g, 67% (based on the metal salt). Mp: 83 C. Anal. calc. for C12H17N2O4S2V (368.34 g mol\n1): C, 39.13; H, 4.65; N, 7.61; S, 17.41. Found: C, 39.29; H, 3.84; N, 8.20; S, 19.75%. IR (KBr), cm 1: n(OH) 3425 w, n(C]N) 1596 s, n(C–O) 1543 m, n(N– N) 1028 s. Mass spectrometry, m/z (%): 336 (54) {M-CH3OH}.\n2.3.3. Synthesis of bis-(S-ethyl-3-(2-hydroxyphenyl)methylenedithiocarbazato)manganese(IV) (3). 3 mL of a methanol solution of L (0.020 g, 0.083 mmol) was added to Mn(OAc)2$4H2O (0.010 g, 0.041 mmol) in the same solvent (3 mL). The mixture was reuxed for 4 h at 70 C on a water bath and the resulting dark precipitate was ltered off and dried in a desiccator over silica gel. Crystals suitable for X-ray crystallography were obtained by diffusion of n-hexane into a solution of the crude product in methanol.\nThis journal is © The Royal Society of Chemistry 2018\nO pe\nn A\ncc es\ns A\nrt ic\nle . P\nub lis\nhe d\non 1\n4 D\nec em\nbe r\n20 18\n. D ow\nnl oa\nde d\non 1\n/2 0/\n20 19\n1 0:\n34 :0\n7 PM . T hi s ar tic le is li ce ns ed u nd er a C re at iv e C om m on s A ttr ib ut io nN on C om m er ci al\n3 .0\nU np\nor te\nd L\nic en\nce .\nIntense green plate-like crystals, yield: 0.030 g, 67% (based on the metal salt). Mp: 182 C. Anal. calc. for C20H20MnN4O2S4 (530.98 g mol 1): C, 45.19; H, 3.97; N, 10.54; S, 24.12. Found: C, 46.33; H, 4.00; N, 10.43; S, 27.14%. IR (KBr), cm 1: n(C]N) 1596 s, n(C–O) 1572 m, n(N–N) 1015 s, mass spectrometry, m/z (%): 530 (<1) {M}.\n2.3.4. Synthesis of bis-(2-hydroxyphenyl-S-ethyldithiocarbazato-N,O,S)-tin(IV) (4). A solution of SnI4 (0.050 g, 0.080 mmol) in 3 mL of absolute ethanol was added to the L ligand (0.040 g, 0.166 mmol) in 3 mL of the same solvent. The mixture was reuxed for 1.5 h at 80 C on a water bath. Suitable crystals were obtained from slow evaporation of solvent in a refrigerator within one day.\nLight yellow plate-like crystals, Yield: 0.1 g, 85% (based on metal salt). Mp: 255 C. Anal. calc. for C20H20N4O2S4Sn (595.36 g mol 1): C, 40.35; H, 3.39; N, 9.41; S, 21.54. Found: C, 40.10; H, 3.43; N, 9.49; S, 22.37%. IR (KBr), cm 1: n(C]N) 1604 s, n(C]C) 1464 s, n(C–O) 1284 m, n(N–N) 968 s. Mass spectrometry, m/z (%): 595 (<1) {M}. 1HNMR (300 MHz, DMSO-d6) d ppm: 1.344 (t, 3H, J ¼ 7.32 Hz, CH3), 3.217 (q, 2H, J ¼ 7.31 Hz, CH2), 6.740 (d, 1H, H-2), 6.928 (m, 1H, H-4), 7.473 (m, 1H, H-3), 7.665 (dd, 1H, J ¼ 1.76 and 8.01 Hz, H-5), 9.306 (S, 1H, H-7). 13C-NMR (75.6 MHz, DMSO-d6, 296 K) d ppm: 14.92 (C10); 25.80 (C9); 137.55 (C1); 119.21 (C2); 136.71 (C3); 116.55 (C4); 122.11 (C5); 167.64 (C6); 165.19 (C7); 169.28 (C8).\n2.3.5. Synthesis of diiodo-dimethylformamide-(2-hydroxyphenyl-S-ethyldithiocarbazato-N,O,S)-tin(IV) (5). SnI4 (0.050 g, 0.080 mmol) in 3 mL of absolute ethanol was added to an ethanol (3 mL) solution of the L (0.020 g, 0.080 mmol) and the mixture reuxed for 1.5 h on water bath. The resulting solution was kept in a refrigerator for four days. The resulting yellow precipitate was ltered off and dried in a desiccator over silica gel. Crystals suitable for X-ray crystallography were obtained from recrystallization of the precipitate from DMF.\nOrange plate-like crystals, yield: 0.04 g, 37% (based on metal salt). Mp: 160 C. Anal. calc. for C13H17I2N3O2S2Sn (683.94 g mol 1): C, 22.83; H, 2.51; N, 6.14; S, 9.38. Found: C, 23.35; H, 2.49; N, 6.17; S, 9.17%. IR (KBr), cm 1: n(C]N) 1647 s, n(C–O) 1284 m, n(N–N) 10 230 w. Mass spectrometry, m/z (%): 683 (<1) {M}. 1H-NMR (300 MHz, DMSO-d6) d ppm: 1.346 (t, 3H, J ¼ 7.32 Hz, C10H3), 3.220 (q, 2H, J¼ 7.32 Hz, C9H2), 6.739 (dd, 1H, J ¼ 8.51 and 1.01, H2), 6.932 (ddd, 1H, J ¼ 8.02, 7.08 and 1.11, H4), 7.476 (m, 1H, J¼ 7.04 and 1.82, H3), 7.671 (dd, 1H, J¼ 7.96 and 1.77 Hz, H5), 9.314 (s, 1H, H7).\n2.3.6. Synthesis of dichlorido-dimethylsulfoxide-(2hydroxyphenyl-S-ethyldithiocarbazato-N,O,S)-tin(IV) (6). A solution of SnCl2 (0.394 g, 2.078 mmol) in methanol and DMSO (3 : 1 v/v) was added to the L (0.500 g, 2.083 mmol) in the same solvent (6 mL). The resulting yellow solution was reuxed for 2 h on a water bath. Yellow crystals were obtained from slow evaporation of the solvent in a refrigerator over 10 days.\nLight-yellow tablet crystals, yield: 0.91 g, 87% (based on metal salt). Mp: 195 C. Anal. calc. for C12H16Sn N2O2S3Cl2 (506.6 g mol 1): C, 28.48; H, 3.19; N, 5.54; S, 19.01. Found: C, 28.88; H, 3.16; N, 5.98; S, 19.51%. IR (KBr), cm 1: n(C]N) 1600 s, n(C–O) 15 340 m, n(N–N) 1030 w. Mass spectrometry,m/z (%): 506.8 (<1). 1H-NMR (300 MHz, DMSO-d6) d ppm: 1.372 (t,\nThis journal is © The Royal Society of Chemistry 2018\n3H, J ¼ 7.28 Hz, CH3), 2.554 (S, 6H, CH3), 3.234 (q, 2H, J ¼ 7.08 Hz, CH2), 6.982 (m, 1H, H-4), 7.007 (d, 1H, J ¼ 1.08, H-2), 7.551 (td, 1H, H-3), 7.677 (dd, 1H, J ¼ 1.87 and 7.71 Hz, H-5), 9.117 (S, 1H, H-7). 13C-NMR (75.6 MHz, DMSO-d6, 296 K) d ppm: 14.99 (C10); 25.63 (C9); 40.90 (C11, C12); 136.98 (C1); 119.55 (C2); 136.58 (C3); 116.96 (C4); 122.31 (C5); 164.64 (C6); 164.85 (C7); 169.26 (C8)."
    }, {
      "heading" : "2.4. X-ray crystallography",
      "text" : "Suitable crystals of L and 1–6 were mounted on polymer loops and placed in a cold nitrogen stream on a Bruker Smart APEX CCD diffractometer. Full spheres of data were collected under control of the APE 3 program suite.26 The raw data were converted to F2 values with SAINT26 and empirical absorption corrections as well as merging of equivalent reections were performed with SADABS.26 The structures were solved by direct methods (SHELXT27) and rened by full-matrix, least-squares procedures (SHELXL28). Hydrogen atoms attached to carbon were placed in idealized positions while those attached to oxygen were placed in locations derived from difference maps and their coordinates adjusted to give O–H ¼ 0.87 Å. All were included as riding contributions with isotropic displacement parameters tied to those of the attached atoms."
    }, {
      "heading" : "2.5. Biology studies",
      "text" : "2.5.1. Cytotoxicity activity. In order to achieve a better view of potential anticancer properties of the compounds prepared in this work, their cytotoxic activity against the human tumor cell lines Hela and MCF-7 and the normal cell line Cho were determined by MTT assays. For this purpose, 25 cm2 tissue culture asks were used to grow the cells in an incubator at 37 C in a humidied atmosphere consisting of 5% CO2 and 95% air. A culture medium of RPMI 1640, 10% (v/v) fetal bovine serum, 100 (U mL 1) penicillin, and 100 mg mL 1 of streptomycin was used to maintain the cells. 100 mL volumes of cell solutions were seeded into 96-well plates containing diverse concentrations of L and its complexes and the mixtures incubated for 48 h. Aer 48 h, 20 mL of MTT [3-(4,5-dimethylthiazol2-yl)-2,5-diphenyl tetrazolium bromide], (nal MTT concentration 5 mg mL 1 in phosphate buffered saline) solution was added and the samples incubated for 4 h. Finally, 100 mL of DMSO is added to each well to dissolve the purple formazan formed. The absorbance (A) of all samples at 570 nmwavelength was measured by an ELISA plate reader (TECAN innite M200, Switzerland) at 570/630 nm. All experiments were performed in quadruplicate and evaluated at six concentrations dilution the highest being 200 mM. The IC50 value was dened as the concentration at which 50% of the cells could survive. Themean values and standard deviation for treated groups at different times were calculated. In addition, statistical signicance of differences between untreated and treated groups at different times was determined by using GraphPad Prism 7.0 soware (GraphPad Soware, Inc.).\n2.5.2. HSA-binding studies. To study the binding of the compounds with HSA, a solution of HSA (15 mM) with phosphate buffer solution (pH 7.40) was prepared. The exact\nRSC Adv., 2018, 8, 41795–41809 | 41797\nO pe\nn A\ncc es\ns A\nrt ic\nle . P\nub lis\nhe d\non 1\n4 D\nec em\nbe r\n20 18\n. D ow\nnl oa\nde d\non 1\n/2 0/\n20 19\n1 0:\n34 :0\n7 PM . T hi s ar tic le is li ce ns ed u nd er a C re at iv e C om m on s A ttr ib ut io nN on C om m er ci al\n3 .0\nU np\nor te\nd L\nic en\nce .\nconcentration of HSA was determined spectrophotometrically using the molar extinction coefficient of 35 700 M 1 cm 1. Samples were prepared by dissolving each compound in DMSO with gradual increase in concentration (0, 1, 2 and 13 mM) at room temperature. Appropriate concentrations of drug–protein solutions were prepared by mixing protein solutions with different concentrations of drug solutions. The nal concentration of DMSO aer addition of the drug solution to the protein solution was 1% of the total volume. For uorescence determination, spectra (lex ¼ 280 nm) in the wavelength range of 285–500 nmwere recorded at 298 K and the slit width was 5/5. Absorption titration experiments with the same concentrations for protein and compounds were also done."
    }, {
      "heading" : "2.6. X-ray powder diffraction studies",
      "text" : "To prepare the nano-particles, 10 mL of a 0.01 M solution of the metal salt was positioned in an ultrasonic probe with a maximum power output of 200 W. Into this solution, 10 mL of a 0.01 M solution of the L was added dropwise. The precipitate obtained was ltered off and dried in air. The X-ray diffraction pattern of the complexes was determined for a 2q range of 6.000 to 79.990 using the unit cell data from the single crystal determinations. The morphology and size of the nanoparticles were investigated by scanning electron microscopy (SEM)."
    }, {
      "heading" : "3. Results and discussion",
      "text" : ""
    }, {
      "heading" : "3.1. IR and NMR studies",
      "text" : "In the infrared spectrum of L (Fig. SI 1a†), a broad, medium intensity band in the region 3200–3400 cm 1 is assigned to the OH stretching vibration. This band disappears aer complexation and indicates the coordination takes place through the deprotonated phenolic oxygen atom.29–31 Also the medium intensity n(C–O) band at 1260 cm 1 in the L undergoes a blue shi in the complexes (Fig. SI 1b–g†) which provides further evidence of involving the phenolic oxygen atom in coordination.32\nThe bands at 1307 and 3108 cm 1 are assigned to n(C]S) and n(N–H) vibrations respectively.33,34 Disappearance of these bands in the spectra of the complexes suggest the coordination of the S atom to the metal ion. Also, the absence of a n(S–H) band at approximately 2750 cm 1 emphasizes the existence of the thione tautomeric form in the solid state.35 A strong n(C]N) band is observed at 1613 cm 1 in the L spectrum which shows a red shi in the metal complexes and conrms coordination of the azomethine nitrogen atom to the metal ion.10,34 Finally, nsy(cis-MoO2), nasy(cis-MoO2)36 and n(V]O)37,38 frequencies appear at 842, 929 and 990 cm 1 respectively.39\nIn the 1HNMR spectra of compounds (Fig. SI 2a–e†), the aromatic protons are observed as multiplet signals in the range 6.5–7.9 ppm.40 The triplet and quartet signals which are, respectively, observed in the ranges 1.2–1.4 and 3.2–4.2 ppm correspond to the ethyl protons.41 In the spectrum of the ligand (L), however, the sharp signal at 10.26 ppm is assigned to the phenolic proton as it disappears upon D2O addition (Fig. SI 2f†).42 The absence of this signal in the spectra of the complexes\n41798 | RSC Adv., 2018, 8, 41795–41809\nconrms that coordination occurs through the phenolic oxygen.43 Also the singlet signal assigned to the imine hydrogen in the L spectrum (8.54 ppm) shis down eld aer complexation44,45 while satellites appear around this signal in compounds 4–6 which correspond to coupling of this hydrogen with 117Sn and 119Sn isotopes,46 all of which indicate coordination of this nitrogen atom.\nIn the 13C-NMR spectra of the compounds (Fig. SI 3a–e†), signals of the aromatic carbons are in the range 116–164 pm. The signals of the thioamide and azomethine carbons in the L spectrum are observed at 196 and 145 ppm respectively and are shied upeld aer complexation.47 This indicates that the thioamide and azomethine carbons are close to complexation sites (see Experimental section for more details about other carbons).48"
    }, {
      "heading" : "3.2. Thermogravimetric analysis",
      "text" : "TGA and DTG curves of complexes 1–6 (Fig. SI 4a–f†) were carried out over a temperature range from room temperature up to 950 C. The thermal studies using TGA methods show a multistep decomposition pattern in the thermograms of the metal complexes under investigation.\nThe data from thermogravimetric analysis show that decomposition of compound 1 occurs in four steps. The degradation starts over the temperature range 28–145 C with a mass loss of 7.90% (calc. 8.04%), consistent with removal of the coordinated methanol molecule. Next, weight losses of 26.79% (calc. 26.40%) and 28.83% (calc. 29.40%) are associated with removal of the coordinated L0 which occurs in two consecutive steps over the temperature range 224–719 C. The remaining residue (35.22% of the initial mass) is formulated as MoO3 (calc. 36.14%).12,49\nThe vanadium complex (2) also, in the rst stage of its thermal decomposition, involves loss of the coordinated methanol molecule (8.63% mass loss; calc. 8.69%) over the temperature range of 21–113 C. In the second step, the methoxide ligand is removed by further heating to 217 C (8.30% mass loss; calc. 8.42%). Then, the L0 ligand is removed in three steps with a total mass loss of 60.39% (calc. 60.35%) over the temperature range 178–743 C and VO2 remains as the nal product with a mass of 26.60% (calc. 22.51%).49\nComplex 3 decomposes in three steps. No weight loss is seen up to 150 C. The coordinated L0 in two consecutive steps are eliminated over the temperature range 153–570 C with a mass loss of 22.76% (calc. 23.02%) for release of S-ethyl groups and a mass loss of 32.96% (calc. 33.61%) for release of another part of the L0 ligand. The residue at the temperature of 570 C is a mixture of metal oxides comprising 25.59% of the initial mass which at 822 C converts to Mn2O3 with a mass of 19.21% (calc. 21.40%).50–52\nTGA and DTG curves of 4, 5 and 6 shows two thermal decomposition stages and for all the three complexes, SnO2 remains as the nal product.46\nIn 4, the rst step consists of the loss of iodine groups and coordinated dimethyl formamide molecule with a mass of 42.88% (calc. 47.80%) at temperature range of 100–370 C. The\nThis journal is © The Royal Society of Chemistry 2018\nFig. 1 Views of L ligand and complexes showing the atomic numbering and 50% probability displacement ellipsoids.\nO pe\nn A\ncc es\ns A\nrt ic\nle . P\nub lis\nhe d\non 1\n4 D\nec em\nbe r\n20 18\n. D ow\nnl oa\nde d\non 1\n/2 0/\n20 19\n1 0:\n34 :0\n7 PM . T hi s ar tic le is li ce ns ed u nd er a C re at iv e C om m on s A ttr ib ut io nN on C om m er ci al\n3 .0\nU np\nor te\nd L\nic en\nce .\nsecond step indicates the decomposition of the organic part (L0) up to 590 C with mass loss of 30.52% (calc. 32.50%) and formation of SnO2.\nLikewise, in 5, the rst step involves the removal of dimethyl sulfoxide molecule, chlorine atoms and CS2–ethyl group with a mass of 46.19% (calc. 50.25%) at temperature range of 21–\nThis journal is © The Royal Society of Chemistry 2018\n357 C. By increasing of temperature up to 725 C, the residual organic part decomposes with a loss of 26.36% (calc. 26.13%) of the complex mass, and the SnO2 with mass of 26.40% (calc. 29.79%) remains as the nal product.\nFinally, compound 6 is stable up to 195 C. The L0 removes during two steps at temperature range of 195–580 C and the\nRSC Adv., 2018, 8, 41795–41809 | 41799\nT ab\nle 1\nC ry st al\nan d re fi n e m e n t d e ta ils\nfo r co\nm p le xe\ns\nL 1\n2 3\n4 5 6 C h em ic al fo rm u la C 2 0H 2 2 N 4 O 2 S 4 C 1 1 H 1 4 M oN 2 O 4 S 2 C 1 2H 1 7 N 2 O 4 S 2 V C 2 0 H 2 0 M n N 4 O 2S 4 C 2 0H 2 0 N 4 O 2 S 4 Sn C 1 3 H 1 7 I 2 N 3 O 2 S 2 Sn\nC 1 2H\n1 6C\nl 2 N 2 O 2 S 3 Sn\nM r\n47 8. 65\n38 9. 30\n36 8. 33\n53 1. 58\n59 5. 33\n68 3. 90\n50 6. 04\nC ry st al\nsy st em\nM on\noc li n ic\nM on\noc li n ic\nT ri cl in ic\nM on\noc li n ic\nM on\noc li n ic\nO rt h or h om\nbi c\nT ri cl in ic\nSp ac e gr ou\np C 2/ c\nP2 1 /c\nP 1 C 2/ c\nC 2/ c\nPb ca P 1 U n it ce ll (Å , ) a 23 .7 12 (2 ) 10 .0 78 8( 8) 8. 02 81 (1 7) 7. 77 64 (1 0) 7. 79 57 (7 ) 18 .9 99 (1 1)\n8. 52\n93 (4 )\nb 9. 10\n25 (8 )\n9. 86\n39 (8 )\n10 .1 27\n(2 )\n24 .0 56\n(3 )\n24 .1 97\n(2 )\n8. 97\n8( 5)\n9. 31\n73 (5 )\nc 10\n.4 51\n7( 9)\n14 .4 72\n5( 11\n) 11\n.1 04\n(2 )\n12 .1 30\n8( 15\n) 12\n.3 00\n3( 10\n) 23\n.5 12\n(1 4)\n12 .6 06\n7( 6)\na 90\n90 11\n0. 55\n4( 3)\n90 90\n90 10\n0. 63\n5( 1)\nb 10\n5. 35\n3( 1)\n90 .6 90\n(1 )\n11 0. 25\n0( 3)\n10 4. 46\n2( 2)\n10 1. 15\n7( 1)\n90 10\n8. 83\n1( 1)\ng 90\n90 94\n.7 85\n(3 )\n90 90\n90 94\n.3 34\n(1 )\nV (Å\n3 )\n21 75\n.3 (3 )\n14 38\n.7 (2 )\n77 1. 2( 3)\n21 97\n.4 (5 )\n22 76\n.3 (3 )\n40 11\n(4 )\n92 2. 06\n(8 )\nZ 4\n4 2\n4 4\n8 2\nR ad\nia ti on\nty pe\nM o/ K a (l ¼\n0. 71\n07 5 Å )\nM o/ K a (l ¼\n0. 71\n07 5 Å )\nM o/ K a (l ¼\n0. 71\n07 5 Å )\nM o/ K a (l ¼\n0. 71\n07 5 Å )\nM o/ K a (l ¼\n0. 71\n07 5 Å )\nM o/ K a (l ¼\n0. 71\n07 5 Å )\nM o/ K a (l ¼\n0. 71\n07 5 Å )\nr (g\ncm 1 )\n1. 46\n2 1. 83\n9 1. 58\n6 1. 60\n7 1. 73\n7 2. 26\n5 1. 82 3 m (m m 1 ) 0. 46 2 1. 21 5 0. 92 9 1. 00 7 1. 51 5 4. 57 1 2. 02 0 C ry st al si ze (m m ) 0. 06 0 0. 08 0 0. 20 0 0. 09 0 0. 13 0 0. 16 0 0. 12 0 0. 21 0 0. 24 0 0. 03 3 0. 08 5 0. 21 4 0. 06 0 0. 14 0 0. 24 0 0. 04 0 0. 10 0 0. 28 0 0. 06 0\n0. 11\n0\n0. 29 0 T (K ) 10 0 10 0 10 0 10 0 10 0 10 0 10 0 F( 00 0) 10 00 80 0 38 0 10 92 11 92 25 60 50 0 N o. of re  s. 10 13 0 27 17 8 14 30 5 21 21 7 22 19 0 72 50 5 18 01 3 R 1 [I $ 2s (I )] 0. 03 78 0. 02 78 0. 46 4 0. 03 99 0. 03 51 0. 03 62 0. 02 91 R 1 (a ll d at a) 0. 05 07 0. 03 41 0. 63 4 0. 05 20 0. 04 13 0. 04 97 0. 03 69 w R 2 0. 09 70 0. 07 52 0. 13 11 0. 11 04 0. 10 32 0. 08 84 0. 06 32 G O F on F2 1. 07 9 1. 08 3 1. 02 6 1. 09 9 1. 14 6 1. 08 1 0. 91 7 La rg es t d iff .P ea k/ h ol e (e Å 3 ) 0. 49 7, 0 .2 39 1. 60 4, 0 .3 55 1. 14 9, 0 .3 80 0. 91 5, 0 .2 85 1. 62 4, 0 .5 80 1. 90 9, 0 .8 69 1. 24 7, 0 .8 71\n41800 | RSC Adv., 2018, 8, 41795–41809 This journal is © The Royal Society of Chemistry 2018\nO pe\nn A\ncc es\ns A\nrt ic\nle . P\nub lis\nhe d\non 1\n4 D\nec em\nbe r\n20 18\n. D ow\nnl oa\nde d\non 1\n/2 0/\n20 19\n1 0:\n34 :0\n7 PM . T hi s ar tic le is li ce ns ed u nd er a C re at iv e C om m on s A ttr ib ut io nN on C om m er ci al\n3 .0\nU np\nor te\nd L\nic en\nce .\nO pe\nn A\ncc es\ns A\nrt ic\nle . P\nub lis\nhe d\non 1\n4 D\nec em\nbe r\n20 18\n. D ow\nnl oa\nde d\non 1\n/2 0/\n20 19\n1 0:\n34 :0\n7 PM . T hi s ar tic le is li ce ns ed u nd er a C re at iv e C om m on s A ttr ib ut io nN on C om m er ci al\n3 .0\nU np\nor te\nd L\nic en\nce .\nSnO2 withmass loss of 22.7% (calc. 25.31%) remains as the nal product."
    }, {
      "heading" : "3.3. X-ray crystal structures",
      "text" : "Molecular structures were determined by single crystal X-ray diffraction for the L and all six complexes and ORTEP drawings are shown in Fig. 1. Crystal data and renement results for the compounds are listed in Table 1.\nThe sample of the L ligand material used for the X-ray structure was found to be a dimer with an S–S bond. Formation of the S–S bond is a consequence of S–H oxidation which is a phenomenon which frequently happen in the amino acid cysteine (Scheme 1).45\nThe S–S bond length in hydrogen disulde is 2.06 Å, however, formation of this bond with a length of 2.045 Å in the L is close to the length of the bond in other compounds.53 The torsion angle S10–S1–C8–S2 ( 8.86(8) Å) shows that the molecule is not planar and is twisted. In fact, the two equal fragments are perpendicular to each other in the molecule. The intramolecular O1–H1/N1 hydrogen bonding creates a S1\n1(6) graph set. Also, another intramolecular interaction between the S1 and O1 atoms leads to formation of a nine-membered ring (S1/C8/N2/N1/C7/C6/C1/O1/H1) with S1\n1(9) graph set (Fig. 2). Adjacent molecules connect to each other by C10–H10A/ O1i (2.644 Å) (symm. code i: 1 x, 1 y, z) and C7–H7/O1 (2.692 Å) hydrogen bonds along the c axis. Additionally, the C5– H5/Cg\nii (Cg: C1–C6) (3.715 Å) (symm. code ii: 1 x, 1 y, 1 z) interaction plays a decisive role in the development of these chains. These chains expand through C2–H2/Cg\niii (Cg: C1–C6) (2.865 Å) (symm. code iii: 1 x, 1 y, 1 z) interaction in the bc plane and complete second and third dimensions (Fig. SI 5a and b†).\nIn the complexation the S–S bond of the L is broken and two L0 is formed (Scheme 1). The L0 ligand acts as a tridentate chelate and connects to the metal ion through the deprotonated phenolic oxygen, the azomethine nitrogen and the thioamide sulfur atom in 1–6. All the complexes are six coordinated and exhibit a distorted octahedral conguration. The asymmetric\nScheme 1 Formation of the S–S bond in cysteine.\nThis journal is © The Royal Society of Chemistry 2018\nunits of 1, 3, 4 and 5 are composed of one complete molecule and for 2 and 6 only half of the molecule lies in the asymmetric unit. Selected bond lengths and angles are listed in Table 2.\nIn all these complexes, the coordination of the L0 to the central metal forms one ve- and one six-membered chelate ring. These two rings are not coplanar and therefore it can be concluded that the L02 is coordinated to the central metal with steric strain. Moreover, the greater electronegativity of oxygen atom over sulfur atom causes shortening of the oxygen–metal bond which leads to an out-of-plane orientation of the oxygen atom within the six-membered ring. Among these complexes, compound 5 has the longest M–S bond (2.4910(16) Å) which causes the greatest amount of oxygen atom deviation (0.278 Å) from the M, N1, C7, C6, C1, O1 mean plane and compound 2 has the shortest M–O bond (1.869(17) Å). In 1, the O1 atom bears such a strain that it is 0.16 Å off the mean plane of the sixmembered ring (Mo1, N1, C7, C6, C1, O1). The Mo1–O1 and Mo1–S1 bond lengths are 1.9284(14) and 2.4568(5) Å respectively. However, the Mo1–O2 (1.702(2) Å) and Mo1–O3 (1.703(1) Å) bonds are approximately the same length, which conrms the equal distribution of electron density of oxido atoms around the central metal. Oxido atoms, O2 and O3, are oriented cis to each other with an angle of 105.46(7) . All lengths and angles around the central atom are almost equal to those of the similar compounds reported elsewhere.54–56 The L0 and O3 atom occupy the equatorial positions while methanol solvent and the O2 atom are in axial positions. The O2 and O4 atoms are trans relative to each other with angle of 169.59(7) . In this compound, the adjacent molecules form a dimer with an R2\n2(10) graph set through pairwise hydrogen bond of O4–H4A/ N2i (1.913(2) Å) (symm. code i: 1 x, 1 y, 1 z). These dimers connect to each other through the hydrogen bond C9ii–H9Aii/ O2 (2.543 Å) (symm. code ii: x, 1.5 y, 1/2 + z) and form a onedimensional chain in the direction of the ( 567) plane. Likewise, through C9–H9A/O2iii and C4–H4A/S1iv (2.961 Å) (symm. code iii and iv: 1 x, 1/2 + y, 1/2 z and x, 1 + y, z) hydrogen bonds the second dimension forms along the b axis. The planes thus created connect to each other through C2–H2/\nRSC Adv., 2018, 8, 41795–41809 | 41801\nFig. 2 Display of the intramolecular hydrogen bonds.\nO pe\nn A\ncc es\ns A\nrt ic\nle . P\nub lis\nhe d\non 1\n4 D\nec em\nbe r\n20 18\n. D ow\nnl oa\nde d\non 1\n/2 0/\n20 19\n1 0:\n34 :0\n7 PM . T hi s ar tic le is li ce ns ed u nd er a C re at iv e C om m on s A ttr ib ut io nN on C om m er ci al\n3 .0\nU np\nor te\nd L\nic en\nce .\nO3v (2.606 Å) (symm. code v: x, 1.5 y, 1/2 + z) hydrogen bonds along the c direction to generate the three dimensional structure (Fig. SI 5c–f†).\nIn complex 2, also due to steric strain the vanadium center moves from the mean coordination plane toward the axial position by about 0.303(3) Å. The axial positions are occupied by the methanol and O2 atom and the L0 ligand and methoxy groups ll the equatorial positions. The angle between the O2 and O4 atoms (172.98(8) ) is higher than compound 1. In this crystalline structure, just like 1, adjacent molecules form dimers and create ten member graph set R2 2(10) through\nTable 2 Selected bond lengths (Å) and angles ( )\nL 1 2 C7–N1 1.2864(18) 1.300(2) 1.301(3) C8–N2 1.2859(17) 1.300(3) 1.311(3) S1–C8 1.7917(13) 1.729(2) 1.719(2) S2–C8 1.7413(13) 1.742(2) 1.746(2) C1–C6 1.4106(19) 1.408(3) 1.416(3) C1–O1 1.3516(17) 1.349(2) 1.340(3) N1–N2 1.4050(16) 1.397(2) 1.414(3) S2–C9 1.8201(14) 1.807(2) 1.818(3) M1–N1 — 2.2821(16) 2.152(2) M1–S1 — 2.4568(5) 2.4183(9) M1–O1 — 1.9284(14) 1.8699(17) M1–O2 — 1.7017(16) 1.5904(18) S1–C8–S2 103.83(4) 119.81(12) 126.61(19) N1–N2–C8 111.96(11) 115.03(16) 112.12(19) O1–C1–C6 122.28(12) 121.64(18) 120.5(2) C7–N1–N2 113.72(11) 113.30(16) 113.57(19) C8–S2–C9 99.47(6) 104.36(10) 104.66(12) N2–C8–S2 121.76(10) 113.75(14) 120.26(18) O2–M1–O1 — 100.02(7) 99.83(8) O2–M1–N1 — 93.99(6) 94.44(8) O1–M1–N1 — 82.42(6) 84.55(8) N1–M1–S1 — 76.14(4) 77.54(6) O1–M1–S1 — 154.98(5) 156.89(6) O2–M1–S1 — 94.24(6) 96.04(7) O2–M1–O3 — 105.46(7) 102.95(9) C8–S1–M1 — 100.08(7) 98.73(8)\n41802 | RSC Adv., 2018, 8, 41795–41809\npairwise hydrogen bonds O4–H4A/N2i (1.963 Å) (symm. code i: 1 x, 1 y, 1 z). The preformed dimers form onedimensional chains in the direction of the c axis through the hydrogen bonds C9–H9A/Cg, C12–H12C/O2\nii (2.681 Å) and C5i–H5i/O2iii (2.665 Å) (symm. code ii: 2 x, 1 y, 1 z, iii: 1 + x, y, z). Moreover, the C2–H2/O1iv (symm. code iv: 1 x, 1 y, z) hydrogen bond is responsible for the formation of the second dimension along the ac plane and the last dimension is formed through C4–H4/Sv and C5–H5/C11vi (symm. code v: x, 1 + y, 1 + z, vi: x, 1 + y, z) interactions along the b axis (Fig. SI 5g–j†).\n3 4 5 6 1.298(3) 1.290(3) 1.301(6) 1.286(3) 1.296(3) 1.302(4) 1.301(6) 1.289(3) 1.735(2) 1.741(3) 1.753(5) 1.739(3) 1.747(2) 1.754(3) 1.754(5) 1.760(3) 1.420(3) 1.418(4) 1.423(6) 1.426(4) 1.330(2) 1.339(3) 1.343(5) 1.338(3) 1.410(2) 1.395(3) 1.401(5) 1.406(3) 1.822(2) 1.821(3) 1.820(5) 1.818(3) 1.9836(16) 2.173(2) 2.203(4) 2.183(2) 2.3196(6) 2.4827(7) 2.4910(16) 2.4624(7) 1.9036(15) 2.045(2) 2.040(3) 2.0109(18) — — 2.220(3) 2.1662(17) 113.70(12) 111.35(15) 111.6(2) 111.13(15) 111.69(16) 114.2(2) 114.5(4) 115.6(2) 122.81(18) 124.1(2) 123.5(4) 124.7(2) 115.13(16) 116.3(2) 114.8(4) 115.8(2) 103.08(10) 103.69(14) 102.8(2) 102.32(13) 120.37(15) 119.4(2) 118.7(3) 120.0(2) — — 82.32(13) 81.51(7) — — 79.97(13) 83.41(7) 91.67(6) 86.46(8) 84.26(13) 87.84(7) 82.07(5) 79.25(6) 79.24(10) 80.32(6) 91.46(5) 165.58(6) 161.79(10) 165.95(5) — — 87.24(10) 89.59(5) — — — — 94.10(7) 92.60(9) 93.97(15) 102.32(13)\nThis journal is © The Royal Society of Chemistry 2018\nTable 3 IC50 values (mean SDa (mM)) of compounds against three of cell lines\nCell lines\nIC50 SD (mM)a\nHela MCF-7 CHO"
    }, {
      "heading" : "L 0.1766 0.022 0.4762 0.0261 0.4698 0.0236",
      "text" : ""
    }, {
      "heading" : "1 0.846 0.023 1.067 0.0223 0.6628 0.224",
      "text" : ""
    }, {
      "heading" : "2 0.0506 0.0226 0.6692 0.0243 0.9544 0.0186",
      "text" : ""
    }, {
      "heading" : "3 0.3415 0.0232 0.7031 0.0241 0.8267 0.025",
      "text" : ""
    }, {
      "heading" : "4 0.6842 0.012 0.5862 0.0244 1.456 0.0246",
      "text" : ""
    }, {
      "heading" : "5 0.6842 0.02 1.048 0.0247 0.3179 0.0254",
      "text" : ""
    }, {
      "heading" : "6 0.05065 0.0226 0.7018 0.0247 1.236 0.0262",
      "text" : "Cisplatin 0.324 0.023 0.67430 0.023 1.347 0.025 a Data are presented as mean SD (standard deviation). All experiments were independently performed at least four times.\nO pe\nn A\ncc es\ns A\nrt ic\nle . P\nub lis\nhe d\non 1\n4 D\nec em\nbe r\n20 18\n. D ow\nnl oa\nde d\non 1\n/2 0/\n20 19\n1 0:\n34 :0\n7 PM . T hi s ar tic le is li ce ns ed u nd er a C re at iv e C om m on s A ttr ib ut io nN on C om m er ci al\n3 .0\nU np\nor te\nd L\nic en\nce .\nIn compounds 3 and 4, the central metal in its +IV oxidation state surrounded by two tridentate chelate ligands (L0). In 3 and 4, respectively, the two L0 coordinate to the manganese and tin ions through the deprotonated phenol oxygen, the azomethine nitrogen and the thioamide sulfur donor atoms. In the coordination sphere, the two phenolic oxygen atoms are cis to one another as are the thioamide sulfur atoms with the two azomethine nitrogen atoms disposed trans to one another. The O1 atom deviation from the coordination plane is 0.217 Å and 0.227 Å in 3 and 4 respectively. It seems that steric strain is higher in 4. However, in both compounds the C4–H4/S1i (2.920 Å for 3 and 2.883 Å for 4) (symm. code i: 1/2 + x, 1/2 + y, 1/2 + z) interaction leads to formation of one-dimensional chains in the a + c direction. These chains within the ( 10 1) plane form 2D sheets through chalcogen–chalcogen S2/S2ii (ii: 1 + x, 1 y, 1/2 + z) (3.403 Å) interactions and nally the planes expand by C9–H9B/C9iii (iii: 1 + x, y, 1 + z) interactions to construct the 3D supramolecular network (Fig. SI 5k–m†).\nFig. 3 Fluorescence quenching spectra of HSA in the presence of increas 298 K.\nThis journal is © The Royal Society of Chemistry 2018\nIn the structure of 5, the deprotonated L0 and one iodine atom are located in equatorial positions and the other iodine atom and the DMF solvent are placed in the axial position. Iodine atoms are positioned cis relative to each other (97.84(2) ) which angle is 7 higher than the idealized 90 for a regular octahedron geometry. Interactions such as C9–H9A/N2i, C13– H13C/I1ii (3.047 Å) and C7–H7/Cg\ni (symm. code i: 1.5 x, 1/ 2 + y, 1 z, ii: x, 1 + y, z) creates chains along the b axis direction. The hydrogen bonding C13–H13B/S2iii (2.985 Å), C12–H12A/O1vi (2.451 Å) and C11–H11/S2iii (2.975 Å) (symm. code iii: 1 x, y, 1 z, vi: 1/2 + x, 1 + y, 1/2 z) forms the second dimension along the –a + c direction. The last dimension is formed along the –a c direction through C12v–H12Av/ O1, C11vi –H11vi/S2vi and C13vi–H13Bvi/S2vi (symm. code v: 1 x, 1.5 + y, 1/2 + z, vi: 1/2 + x, 1/2 y, 1 z) hydrogen bonds (Fig. SI 5n–p†).\nThe crystalline structure of 6 is similar to that of 5, in which the two chlorine atoms are arranged cis to each other (96.81(3) ) and the angle is 6 higher than the idealized 90 for a regular octahedron geometry and 2 higher than the reported similar structure by Souse et al.,57 Therefore, the polyhedron around the Sn(IV) atom is best described as a distorted octahedral. The deprotonated L0 and one chlorine atom are located at the equatorial positions and the other chlorine atom and the DMSO solvent are in the axial positions.\nThe three-dimensional structure is formed according to the following interactions. The C11–H11A/C10i (2.899 Å), C7– H7/Cl2ii (2.819 Å), C10–H10C/Cl2ii (3.397 Å) and H12B– C12/Cl2 (2.868 Å) interactions (symm. code i: x, y, 1 + z, ii: 2 x, 1 y, 1 z) form chains along the c axis direction. The molecules form the second dimension along the a axis direction via the hydrogen bonds C11–H11A$$$ Cl2iii, C12–H12C/Cl1iii and C11–H11B/Cg iv (symm. code iii: 1 x, y, z, iv: 1 x, 1 y, z). The C4–H4C/Cl2v (symm. code v: x, 1 + y, z) interaction along the b axis forms the third dimension (Fig. SI 5q–s†).\ning concentration of L. [HSA]¼ 15 mM, [L]¼ 0–14 mM, lex¼ 280 nm, T¼\nRSC Adv., 2018, 8, 41795–41809 | 41803\nFig. 4 (a) Stern–Volmer plot for quenching of HSA (15 mM) fluorescence by L at different concentrations (lex¼ 280 nm, lem¼ 343 nm); (b) plot of F0\nF0 F vs. 1/[L\n2 ] for HSA in the presence of increasing concentrations of L at T ¼ 298 K (lex ¼ 280 nm, lem ¼ 343 nm); (c) double-log plots for\nthe fluorescence quenching of the HSA by L.\nO pe\nn A\ncc es\ns A\nrt ic\nle . P\nub lis\nhe d\non 1\n4 D\nec em\nbe r\n20 18\n. D ow\nnl oa\nde d\non 1\n/2 0/\n20 19\n1 0:\n34 :0\n7 PM . T hi s ar tic le is li ce ns ed u nd er a C re at iv e C om m on s A ttr ib ut io nN on C om m er ci al\n3 .0\nU np\nor te\nd L\nic en\nce .\nAll bond lengths in these compounds are similar to those observed in reported compounds.15,58,59 The S1–C8 and S2–C8 bond distances are in the range 1.729(2) Å to 1.792(13) Å for the new compounds which suggest the S–C bond is very close to a single bond. The N1–C8 and N2–C8 bond lengths are between 1.285(17) Å and 1.311(3) Å consistent with substantial double bond character. The observed values for the N1–N2 bond (1.395(3) Å to 1.414(3) Å) shows that the bond is shorter than a single N–N bond (1.44 Å). This variation in bond lengths shows that a signicant p-charge delocalization occurs within the SSCNNC fragment.\n3.4. In vitro cytotoxicity study\nTo use a substance as a drug, a cytotoxicity test is required. If it does not show cytotoxicity or just reveals a lower level than the determined standards and if other tests are passed it could enter the pharmaceutical marketing. One of the most important methods to measure cytotoxicity is the MTT assay.60 MTT is a compound that reduces in the presence of mitochondria dehydrogenase enzyme and its yellow color changes to violet.\nColor intensity is proportional to the number of live cells.61 In this method, the cell is exposed to various concentrations of the target material and then evaluated for cell death indices.62,63\nThe in vitro cytotoxicity evaluation results in three cell lines for the L and complexes 1–6 are summarized in Table 3 (see graphs in Fig. SI 6a–c†).\nCytotoxicity evaluation results reveal that all complexes exhibit good cytotoxic activity. L and complexes 2 and 6 showed IC50 values lower than cisplatin against Hela cell and likewise complexe 4 and L against MCF-7 cell which indicating a greater cytotoxicity and anticancer activity of these compounds. So, complex 2 and L show better in vitro therapeutic index than cisplatin against all the two cell lines (see the pictures of the color change of compounds during the MTT experiment in Fig. SI 6d–f†)."
    }, {
      "heading" : "3.5. Interaction of compounds with HSA using uorescence spectroscopy",
      "text" : "3.5.1. Fluorescence quenching of HSA. Investigating the drug–protein interaction is one of the important factors in\nplexes\nTable 5 Values of Ka, n and DG (kJ mol 1) parameters for systems of (compounds + HSA) at T ¼ 298 K\nL 1 2 3 4 5 6 Ka ( 10 5 M 1) SDa 2.98 0.09 1.76 0.1 3.3 0.05 0.8 0.06 1.01 0.03 3.4 0.1 1.8 0.07 n 1.34 1.29 1.29 1.25 1.2 1.3 1.3 DG 41.6 41.3 42.8 39.4 40 43 41.5 a Data are presented as mean SD (standard deviation). All experiments were independently performed three times.\nO pe\nn A\ncc es\ns A\nrt ic\nle . P\nub lis\nhe d\non 1\n4 D\nec em\nbe r\n20 18\n. D ow\nnl oa\nde d\non 1\n/2 0/\n20 19\n1 0:\n34 :0\n7 PM . T hi s ar tic le is li ce ns ed u nd er a C re at iv e C om m on s A ttr ib ut io nN on C om m er ci al\n3 .0\nU np\nor te\nd L\nic en\nce .\nachieving optimal therapeutic dose and awareness of drug– protein binding capacity. Since uorescence spectroscopy is a powerful technique for studying the structure and properties of macromolecules in solution, this technique has been used to investigate the effect of synthetic compounds on human serum albumin.64 There are two link locations for aromatic compounds (in IIA and IIIA subdomains) on albumin.65,66 The three aromatic amino acids of phenylalanine, tyrosine, and tryptophan can absorb in the ultraviolet region of the electromagnetic spectrum and contribute to the intrinsic uorescence of proteins.67 The dominant intrinsic uorophore in proteins is tryptophan. Tryptophan is more important because of its high absorption coefficient. HSA has only one tryptophan residue, Trp-214.68,69 When HSA interacts with other molecules this may change the uorescence of Trp-214 which is a common response to binding of drug-HSA.70 The excitation wavelength of 280 nm (due to the high relative absorption of aromatic tyrosine and tryptophan amino acids) and the emission wavelength of 290 to 500 nm for L and other complexes (Fig. SI 7a–f†) were recorded.71\nThe L effects on the uorescence intensity of HSA is shown in Fig. 3. With increasing concentration of L at 298 K there is a decrease in the uorescence intensity of HSA. The results show that the L quenches the uorescence peak of HSA significantly even before its concentrations become equal to that of HSA.\nFluorescence quenching is described by the Stern–Volmer equation:70\nF0 F ¼ 1þ KSV½Q ¼ 1þ Kqs0 ½Q (1)\nThis journal is © The Royal Society of Chemistry 2018\nwhere F0 and F are the steady-state uorescence intensities in the absence of a compounds and in its presence at [Q] concentration respectively. Kq is the quenching rate constant of the biomolecule, s0 is the average lifetime of HSA without the quencher and its value is 10 8 s,72 and KSV is the Stern–Volmer quenching constant.\nFluorescence quenching occurs by two mechanisms: dynamic and static quenching. Dynamic quenching is due to the collision of the quencher molecules with the desired protein, which reduces uorescence and converts the energy into heat. Static quenching takes place by forming a complex of protein-quencher molecules.25 The formation of this complex produces a new species that has no emission in the range of the previous wavelength. In fact, dynamic quenching and static quenching are caused by diffusion and ground–state complex formation, respectively.73\nThe shape of the SV plot gives information on the quenching mechanism involved. The Stern–Volmer diagram is not linear and is curved (Fig. 4a), indicating that the quencher has created dynamic and static quenching (Fig. SI 7g–l†).\nFor the positive deviation cases a modied SV equation accounting for simultaneous static and dynamic mechanisms was used. For negative deviation cases the following equation was used:\nF0 F0 F ¼ 1 faKSV 1 ½Q þ 1 fa (2)\nwhere fa is the fraction of accessible uorescence while the other parameters are as the same as those dened for classical Stern–Volmer equation (eqn (1)).74\nThe graph is linear (Fig. 4b) and from this one can get fa and KSV. According to the literature, if Kq is more than 2 1010 M 1 S 1 this indicates that static quenching has a major role in quenching process and the role of dynamic quenching is almost insignicant (Fig. SI 7m–r†).75 The KSV values, calculated from eqn (2) for compounds 1–6 are collected in Table 4.\n3.5.2. Binding and thermodynamic parameters, nature of binding forces. Binding parameters for a static quenching interaction are described by:\nlog\nF0 F\nF\n¼ log Ka þ n log½Q (3)\nFrom the plot of log F0 F\nF\nversus log[Q] (Fig. 4c), the\nnumber of binding sites (n) and association constant (Ka) values were calculated for L ligand and complexes (Fig. SI 7s– x†) from the slope and the intercept on the Y-axis respectively (Table 5).76\nRSC Adv., 2018, 8, 41795–41809 | 41805\nFig. 6 The XRD patterns of (a) nanostructure of compound 2 and (b) nanostructure of the L ligand.\nO pe\nn A\ncc es\ns A\nrt ic\nle . P\nub lis\nhe d\non 1\n4 D\nec em\nbe r\n20 18\n. D ow\nnl oa\nde d\non 1\n/2 0/\n20 19\n1 0:\n34 :0\n7 PM . T hi s ar tic le is li ce ns ed u nd er a C re at iv e C om m on s A ttr ib ut io nN on C om m er ci al\n3 .0\nU np\nor te\nd L\nic en\nce .\nThe thermodynamic parameters for reaction between a ligand and a protein are the main evidence for conrming the binding forces. The four types of non-covalent interactions include hydrogen bonds, van der Waals forces, electrostatic and hydrophobic bond interactions which play a key role in ligand binding to proteins.77 The value of the free energy change (DG) was calculated using van't Hoff equation (eqn (4))\nDG ¼ RT ln Ka (4)\nwhere Ka is the binding constant obtained from eqn (3) and R is the universal gas constant and indicates the spontaneity of the binding process of peptide to human albumin.78\nFig. 7 (a) SEM image of complex 2, (b) EDX spectrum analysis of compl\n41806 | RSC Adv., 2018, 8, 41795–41809"
    }, {
      "heading" : "3.6. Powder X-ray diffraction studies accompanied by SEM and TEM images",
      "text" : "Comparisons of the XRD patterns for the nanoparticulate materials obtained by the ultrasonic method show the experimental data are in good agreement with the simulated XRD patterns obtained from single crystal data which also conrm the phase purity of these compounds (Fig. SI 8a–d†). The sharp bands of the samples indicate that the nanoparticles are well crystallized under these synthetic conditions and due to absence of a characteristic bar of impurities in the crystalline phase, the product is highly pure.\nIn Fig. 5b, it is clear that the bands 20, 22, 23, 26 and 27 have much higher intensity which is due to the crystallization\nex 2.\nThis journal is © The Royal Society of Chemistry 2018\nFig. 8 The average nanoparticle size by PLS method.\nO pe\nn A\ncc es\ns A\nrt ic\nle . P\nub lis\nhe d\non 1\n4 D\nec em\nbe r\n20 18\n. D ow\nnl oa\nde d\non 1\n/2 0/\n20 19\n1 0:\n34 :0\n7 PM . T hi s ar tic le is li ce ns ed u nd er a C re at iv e C om m on s A ttr ib ut io nN on C om m er ci al\n3 .0\nU np\nor te\nd L\nic en\nce .\nmethod of the sample. The nanoparticle size is estimated by the Debye–Scherrer formula:79\ndRX ¼ kl/b cos q (5)\nwhere dRX is the crystallite size, k ¼ 0.9 is a correction factor to account for particle shapes, b is the value of full width at halfmaximum intensity (FWHM), l is the wavelength of the Cu target (1.5406 Å), and q is the Bragg angle. The average nanoparticle size for these 5 bands is 90.3 nm.\nThe XRD spectrum of the ligand is compared to the XRD spectrum of the complexes. Fig. 6 illustrates that in the complex spectrum of 2, some bands are removed or displaced regards to the ligand spectrum, indicating a reaction between the ligand and the metal. EDX analyses indicate that compound 2 is successfully obtained via the current synthetic route (Fig. 7b).\nThe average nanoparticle size for bands no. 21, 24, 25 and 27 is 90.4 nm by the Debye–Scherrer formula which is also conrmed by SEM images (Fig. 7a) andmeasurements based on PLS (Fig. 8). See SEM and TEM images, EDS analyses and PLS measurements for samples in SI 8e–o Section.†"
    }, {
      "heading" : "4. Conclusion",
      "text" : "In this work, we synthesized and characterized one novel L ligand and six metal complexes from the dithiocarbazate family. Structural analysis of compounds shows that the L ligand crystallizes as a dimer with S–S bond while in the complexation the S–S bond of the ligand is broken and L0 is formed. L0 act as a tridentate ONS donor ligand. All the complexes are six coordinated with distorted octahedral conguration. These compounds are designed to be able to bind to HSA protein and to have anticancer properties. Studying the interaction of compounds with HSA using uorescence spectroscopy reveals that with increasing concentration of compounds at 298 K the uorescence intensity of HAS decreases and also these compounds quench the uorescence peak of HSA signicantly even before their concentrations become equal to that of HSA. KSV values indicate that static quenching plays a major role in the quenching process and the role of dynamic quenching is\nThis journal is © The Royal Society of Chemistry 2018\nalmost insignicant. Moreover, the cellular toxicity of the compounds was tested against the Hela and MCF-7 cell lines. All compounds exhibit good cytotoxic activity when compared to the clinical drug, cisplatin. Even complexes 2 and 6 show better in vitro therapeutic index than cisplatin against Hela and MCF-7 cell lines. Furthermore, nanoparticles of the complexes are obtained by ultrasonic methods. XRD spectra of the samples conrm that the products are highly pure. The nanoparticle size is estimated by PLS analysis.\nConflicts of interest\nThere are no conict to declare."
    }, {
      "heading" : "Acknowledgements",
      "text" : "This work was supported by the Ferdowsi University of Mashhad (3/39699-1394/11/11) and Buali Research Institute. Authors thank Tulane University for support of the Tulane Crystallography Laboratory."
    } ],
    "references" : [ {
      "title" : "X-Ray Diffraction Procedures: For Polycrystalline and Amorphous Materials, ed",
      "author" : [ "H.P. Klug", "L.E. Alexander" ],
      "venue" : "2nd edn, p. 992",
      "citeRegEx" : "Klug and Alexander,? \\Q1974\\E",
      "shortCiteRegEx" : "Klug and Alexander",
      "year" : 1974
    } ],
    "referenceMentions" : [ ],
    "year" : 2018,
    "abstractText" : "The syntheses of a new set of metal complexes MoO2L0(CH3OH), VOL0(CH3O)(CH3OH), MnL2, SnL 0 2, SnL 0Cl2 and SnL0I2 with a new ligand (L 1⁄4 (2,20(disulfanediylbis((ethylthio)methylene)bis(hydrazin-2-yl-1-ylidene) bis(methanylylidene)) diphenol; L0 1⁄4 S-ethyl-3-(2-hydroxyphenyl)methylenedithiocarbazate are described along with characterization by elemental analysis, mass spectrometry, spectroscopic (IR, Hand CNMR) and TGA techniques. The crystal structures of compounds were determined by single crystal X-ray diffraction analysis and compared to powder X-ray diffraction (PXRD) patterns of the nano complexes obtained using ultrasonic methods. The PXRD results indicate that the compounds synthesized by ultrasonic methods have high crystallinity. The compounds were evaluated in an in vitro cytotoxicity study with two human cancer cell lines. The results of this study revealed that all complexes exhibit good cytotoxic activity when compared to the clinical drug, cisplatin. Interaction of the samples with human serum albumin (HSA) was investigated using fluorescence spectrophotometric methods and the Stern– Volmer quenching constant (KSV) and free energy changes (DG) were calculated at 298 K. The fluorescence quenching method is used to determine the number of binding sites (n) and association constants (Ka) at the same temperatures.",
    "creator" : "Arbortext Advanced Print Publisher 9.1.510/W Unicode"
  }
}